Ubs Group Ag Homology Medicines, Inc. Transaction History

Ubs Group Ag

  • $452 Billion
  • Q3 2024

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 09, 2024
SELL
$0.53 - $1.14 $453 - $974
-855 Reduced 5.92%
13,599 $8,000
Q3 2023

Nov 09, 2023
SELL
$0.84 - $1.43 $1,632 - $2,778
-1,943 Reduced 11.85%
14,454 $16,000
Q2 2023

Aug 11, 2023
BUY
$0.83 - $1.12 $4,255 - $5,742
5,127 Added 45.49%
16,397 $14,000
Q1 2023

May 12, 2023
SELL
$0.91 - $1.69 $2,350 - $4,365
-2,583 Reduced 18.65%
11,270 $11,000
Q4 2022

Feb 08, 2023
SELL
$1.09 - $2.04 $21,147 - $39,578
-19,401 Reduced 58.34%
13,853 $17,000
Q3 2022

Nov 10, 2022
SELL
$1.55 - $3.01 $243,145 - $472,172
-156,868 Reduced 82.51%
33,254 $54,000
Q2 2022

Aug 10, 2022
BUY
$1.39 - $3.12 $230,286 - $516,902
165,674 Added 677.66%
190,122 $375,000
Q1 2022

May 16, 2022
SELL
$2.6 - $4.17 $28,472 - $45,665
-10,951 Reduced 30.94%
24,448 $74,000
Q4 2021

Feb 14, 2022
BUY
$3.64 - $7.78 $83,501 - $178,473
22,940 Added 184.12%
35,399 $129,000
Q3 2021

Nov 15, 2021
BUY
$6.01 - $8.71 $49,852 - $72,249
8,295 Added 199.21%
12,459 $98,000
Q2 2021

Aug 13, 2021
SELL
$6.02 - $9.64 $645,307 - $1.03 Million
-107,194 Reduced 96.26%
4,164 $30,000
Q1 2021

May 12, 2021
BUY
$9.17 - $14.8 $60,201 - $97,162
6,565 Added 6.26%
111,358 $1.05 Million
Q4 2020

Feb 11, 2021
BUY
$8.92 - $13.29 $100,733 - $150,083
11,293 Added 12.08%
104,793 $1.18 Million
Q3 2020

Nov 12, 2020
BUY
$9.94 - $16.59 $929,390 - $1.55 Million
93,500 New
93,500 $1 Million
Q2 2020

Jul 31, 2020
SELL
$12.07 - $19.34 $106,722 - $171,004
-8,842 Closed
0 $0
Q1 2020

May 01, 2020
BUY
$12.5 - $22.04 $85,525 - $150,797
6,842 Added 342.1%
8,842 $137,000
Q4 2019

Feb 14, 2020
SELL
$11.42 - $22.19 $533,405 - $1.04 Million
-46,708 Reduced 95.89%
2,000 $41,000
Q3 2019

Nov 14, 2019
BUY
$14.74 - $22.28 $590,970 - $893,272
40,093 Added 465.39%
48,708 $882,000
Q2 2019

Aug 14, 2019
BUY
$18.35 - $30.34 $130,560 - $215,869
7,115 Added 474.33%
8,615 $169,000
Q1 2019

May 14, 2019
BUY
$19.76 - $29.57 $7,489 - $11,207
379 Added 33.81%
1,500 $42,000
Q4 2018

Feb 14, 2019
SELL
$18.39 - $26.3 $34,536 - $49,391
-1,878 Reduced 62.62%
1,121 $25,000
Q3 2018

Nov 14, 2018
BUY
$15.54 - $22.86 $19,922 - $29,306
1,282 Added 74.67%
2,999 $68,000
Q2 2018

Aug 14, 2018
BUY
$16.49 - $21.55 $28,313 - $37,001
1,717 New
1,717 $35,000

Others Institutions Holding FIXX

# of Institutions
3
Shares Held
66.2K
Call Options Held
0
Put Options Held
0
View Full List

About Homology Medicines, Inc.

FIXX Quotes by TradingView
  • Ticker FIXX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 57,402,000
  • Description
  • Homology Medicines, Inc., a genetic medicines company, focuses on transforming the lives of patients suffering from rare genetic diseases. Its proprietary platform is designed to utilize its human hematopoietic stem cell derived adeno-associated virus vectors (AAVHSCs) to deliver genetic medicines in vivo either through a gene therapy or nucleas...
More about FIXX
Track This Portfolio

Track Ubs Group Ag Portfolio

Follow Ubs Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email